Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Hypersensitivity Reaction

Free Subscription Articles published in N Engl J Med Retrieve available abstracts of 60 articles: HTML format

Single Articles

July 2024
1. PETERS NE, Mac Lochlainn DJ, Dhalla F, Howarth L, et al
   Normalization of C1 Inhibitor in a Patient with Hereditary Angioedema.
   N Engl J Med. 2024;391:56-59.
   PubMed     Abstract available
   
   
   
2. RIEDL MA, Farkas H, Aygoren-Pursun E, Psarros F, et al
   Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks.
   N Engl J Med. 2024;391:32-43.
   PubMed     Abstract available
   
   
   
3. AMERATUNGA R, Longhurst HJ
   New Therapies for Type 1 and Type 2 Hereditary Angioedema.
   N Engl J Med. 2024;391:79-81.
   PubMed    
   
   
   
4. RIEDL MA, Tachdjian R, Lumry WR, Craig T, et al
   Efficacy and Safety of Donidalorsen for Hereditary Angioedema.
   N Engl J Med. 2024;391:21-31.
   PubMed     Abstract available
   
   
   June 2024
5. WRIGHT BL
   Unmasking the Culprits in Eosinophilic Esophagitis Pathogenesis.
   N Engl J Med. 2024;390:2321-2322.
   PubMed    
   
   
   
6. ROTHENBERG ME, Dellon ES, Collins MH, Bredenoord AJ, et al
   Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.
   N Engl J Med. 2024;390:2252-2263.
   PubMed     Abstract available
   
   
   
7. CHEHADE M, Dellon ES, Spergel JM, Collins MH, et al
   Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age.
   N Engl J Med. 2024;390:2239-2251.
   PubMed     Abstract available
   
   
   May 2024
8. WOOD RA, Togias A, Chinthrajah RS
   Omalizumab for the Treatment of Multiple Food Allergies. Reply.
   N Engl J Med. 2024;390:1936.
   PubMed    
   
   
   
9. HUI SHI EN E, Cheng-Chung Wei J
   Omalizumab for the Treatment of Multiple Food Allergies.
   N Engl J Med. 2024;390:1936.
   PubMed    
   
   
   
10. AARON SD, Vandemheen KL, Whitmore GA, Bergeron C, et al
    Early Diagnosis and Treatment of COPD and Asthma - A Randomized, Controlled Trial.
    N Engl J Med. 2024 May 19. doi: 10.1056/NEJMoa2401389.
    PubMed     Abstract available
    
    
    
11. CHEN ST, Cochran RL, Jain S, Stagner AM, et al
    Case 15-2024: A 73-Year-Old Woman with Worsening Rash.
    N Engl J Med. 2024;390:1803-1813.
    PubMed    
    
    
    February 2024
12. WANG S, Dai H
    Crazy-Paving Pattern in Pulmonary Sarcoidosis.
    N Engl J Med. 2024;390:e21.
    PubMed    
    
    
    
13. WOOD RA, Togias A, Sicherer SH, Shreffler WG, et al
    Omalizumab for the Treatment of Multiple Food Allergies.
    N Engl J Med. 2024 Feb 25. doi: 10.1056/NEJMoa2312382.
    PubMed     Abstract available
    
    
    
14. WONG GWK
    Options for Multiple Food Allergies - Food Avoidance or Pharmacologic Treatment?
    N Engl J Med. 2024 Feb 25. doi: 10.1056/NEJMe2400807.
    PubMed    
    
    
    
15. LONGHURST HJ, Lindsay K, Petersen RS, Fijen LM, et al
    CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary Angioedema.
    N Engl J Med. 2024;390:432-441.
    PubMed     Abstract available
    
    
    November 2023
16. MOSNAIM G
    Asthma in Adults. Reply.
    N Engl J Med. 2023;389:10.
    PubMed    
    
    
    
17. BELL KJL, Kazda L, Parker G
    Asthma in Adults.
    N Engl J Med. 2023;389:10.
    PubMed    
    
    
    
18. RABIN AS, Junck L, Shankar HM
    Asthma in Adults.
    N Engl J Med. 2023;389:10.
    PubMed    
    
    
    
19. SELINGER S
    Asthma in Adults.
    N Engl J Med. 2023;389:10.
    PubMed    
    
    
    
20. WONG JCY, Li PH
    Large-Bowel Obstruction from Hereditary Angioedema.
    N Engl J Med. 2023;389:e41.
    PubMed    
    
    
    October 2023
21. KWATRA SG, Yosipovitch G, Legat FJ, Reich A, et al
    Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
    N Engl J Med. 2023;389:1579-1589.
    PubMed     Abstract available
    
    
    
22. JANUSONYTE E, Punchera J
    Shiitake Dermatitis.
    N Engl J Med. 2023;389:1415.
    PubMed    
    
    
    September 2023
23. MOSNAIM G
    Asthma in Adults.
    N Engl J Med. 2023;389:1023-1031.
    PubMed    
    
    
    July 2023
24. AGUSTI A
    Biologics for COPD - Finally Here.
    N Engl J Med. 2023;389:274-275.
    PubMed    
    
    
    
25. WOLKOW N, Romo LV, Edwards CV, Stagner AM, et al
    Case 21-2023: A 61-Year-Old Man with Eyelid Swelling.
    N Engl J Med. 2023;389:166-175.
    PubMed    
    
    
    June 2023
26. SILVERBERG JI, Guttman-Yassky E, Gontijo Lima R
    Lebrikizumab for Moderate-to-Severe Atopic Dermatitis. Reply.
    N Engl J Med. 2023;388:2299-2300.
    PubMed    
    
    
    
27. SMITH B, Engel P, Wu JJ
    Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
    N Engl J Med. 2023;388:2299.
    PubMed    
    
    
    May 2023
28. TOGIAS A
    Good News for Toddlers with Peanut Allergy.
    N Engl J Med. 2023;388:1814-1815.
    PubMed    
    
    
    
29. GREENHAWT M, Sindher SB, Wang J, O'Sullivan M, et al
    Phase 3 Trial of Epicutaneous Immunotherapy in Toddlers with Peanut Allergy.
    N Engl J Med. 2023;388:1755-1766.
    PubMed     Abstract available
    
    
    April 2023
30. CONNOLLY CM, Christopher-Stine L
    Periorbital Edema in Dermatomyositis.
    N Engl J Med. 2023;388:e52.
    PubMed    
    
    
    March 2023
31. SILVERBERG JI, Guttman-Yassky E, Thaci D, Irvine AD, et al
    Two Phase 3 Trials of Lebrikizumab for Moderate-to-Severe Atopic Dermatitis.
    N Engl J Med. 2023 Mar 15. doi: 10.1056/NEJMoa2206714.
    PubMed     Abstract available
    
    
    
32. DELLON ES, Rothenberg ME, Bredenoord AJ
    Dupilumab in Patients with Eosinophilic Esophagitis. Reply.
    N Engl J Med. 2023;388:956-957.
    PubMed    
    
    
    
33. GREUTER T, Schoepfer AM
    Dupilumab in Patients with Eosinophilic Esophagitis.
    N Engl J Med. 2023;388:955-956.
    PubMed    
    
    
    January 2023
34. KAKURAI M, Oya K
    Atopic Eruption of Pregnancy.
    N Engl J Med. 2023;388:357.
    PubMed    
    
    
    December 2022
35. STRAUMANN A
    Biologics in Eosinophilic Esophagitis - Ready for Prime Time?
    N Engl J Med. 2022;387:2379-2380.
    PubMed    
    
    
    
36. DELLON ES, Rothenberg ME, Collins MH, Hirano I, et al
    Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis.
    N Engl J Med. 2022;387:2317-2330.
    PubMed     Abstract available
    
    
    
37. LANG DM
    Chronic Urticaria. Reply.
    N Engl J Med. 2022;387:2103.
    PubMed    
    
    
    
38. ROLLA G
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102-2103.
    PubMed    
    
    
    
39. WEINBERGER M
    Chronic Urticaria.
    N Engl J Med. 2022;387:2102.
    PubMed    
    
    
    
40. BONNIN AJ
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101-2102.
    PubMed    
    
    
    
41. DESCAMPS V
    Chronic Urticaria.
    N Engl J Med. 2022;387:2101.
    PubMed    
    
    
    September 2022
42. LANG DM
    Chronic Urticaria.
    N Engl J Med. 2022;387:824-831.
    PubMed    
    
    
    August 2022
43. PAPI A, Chipps BE, Cappelletti C
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma. Reply.
    N Engl J Med. 2022;387:663.
    PubMed    
    
    
    
44. LIPWORTH BJ, Chan R, Stewart KE
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    N Engl J Med. 2022;387:662-663.
    PubMed    
    
    
    July 2022
45. HUNG WK, Chung WH
    Drug Reaction with Eosinophilia and Systemic Symptoms.
    N Engl J Med. 2022;387:167.
    PubMed    
    
    
    June 2022
46. SCHATZ M
    Another Rescue Therapy Option for Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2022;386:2139-2140.
    PubMed    
    
    
    May 2022
47. PAPI A, Chipps BE, Beasley R, Panettieri RA Jr, et al
    Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma.
    N Engl J Med. 2022 May 15. doi: 10.1056/NEJMoa2203163.
    PubMed     Abstract available
    
    
    April 2022
48. BRYANT-STEPHENS T
    Breaking the Skin Color Barriers for Asthma Medications - It's Not Black, Brown, or White.
    N Engl J Med. 2022;386:1574-1575.
    PubMed    
    
    
    March 2022
49. LONGHURST HJ, Ameratunga R
    An Antisense Oligonucleotide for Hereditary Angioedema.
    N Engl J Med. 2022;386:1083-1085.
    PubMed    
    
    
    
50. BANERJI A, Phadke NA, Gottumukkala R, Sharma R, et al
    Case 8-2022: A 54-Year-Old Woman with Episodes of Swelling.
    N Engl J Med. 2022;386:1071-1079.
    PubMed    
    
    
    
51. FIJEN LM, Riedl MA, Bordone L, Bernstein JA, et al
    Inhibition of Prekallikrein for Hereditary Angioedema.
    N Engl J Med. 2022;386:1026-1033.
    PubMed     Abstract available
    
    
    February 2022
52. ISRAEL E, Cardet JC, Carroll JK, Fuhlbrigge AL, et al
    Reliever-Triggered Inhaled Glucocorticoid in Black and Latinx Adults with Asthma.
    N Engl J Med. 2022 Feb 26. doi: 10.1056/NEJMoa2118813.
    PubMed     Abstract available
    
    
    January 2022
53. BRUSSELLE GG, Koppelman GH
    Biologic Therapies for Severe Asthma.
    N Engl J Med. 2022;386:157-171.
    PubMed    
    
    
    December 2021
54. GONZALEZ BURCHARD E, Borrell LN
    Need for Racial and Ethnic Diversity in Asthma Precision Medicine.
    N Engl J Med. 2021;385:2297-2298.
    PubMed    
    
    
    
55. BACHARIER LB, Maspero JF, Katelaris CH, Fiocchi AG, et al
    Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:2230-2240.
    PubMed     Abstract available
    
    
    
56. ZHANG B, Ma L
    Transverse Nasal Creases.
    N Engl J Med. 2021;385:2281.
    PubMed    
    
    
    October 2021
57. BARDIN PG, Foster PS
    Clinical Translation of Basic Science in Asthma.
    N Engl J Med. 2021;385:1714-1717.
    PubMed    
    
    
    
58. ASKENASE PW
    Rare Skin Reactions after mRNA Vaccination, Similar to Jones-Mote Basophil Responses.
    N Engl J Med. 2021;385:1720-1721.
    PubMed    
    
    
    
59. BRIGHTLING CE, Nair P, Cousins DJ, Louis R, et al
    Risankizumab in Severe Asthma - A Phase 2a, Placebo-Controlled Trial.
    N Engl J Med. 2021;385:1669-1679.
    PubMed     Abstract available
    
    
    
60. WECHSLER ME, Ruddy MK, Pavord ID, Israel E, et al
    Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma.
    N Engl J Med. 2021;385:1656-1668.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hypersensitivity Reaction is free of charge.